UCN-01 and Fludarabine in Treating Patients With Recurrent or Refractory Lymphoma or Leukemia

NCT00019838 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Leukemia
Lymphoma

Interventions

DRUG: 7-hydroxystaurosporine
DRUG: fludarabine phosphate

Sponsor

National Cancer Institute (NCI)